Fig. 4From: Multi-omics characterization of a scoring system to quantify hypoxia patterns in patients with head and neck squamous cell carcinomaA Consensus matrixes for 770 HNSCC samples based on the DEGs among the three hypoxia clusters. Three subtypes were determined for all samples (k = 3). B OS differences among the three gene clusters. C Expression of hypoxia-related DEGs in different hypoxia clusters and gene clusters. D–E OS differences between HHSG and LHSG using a combination of TCGA-HNSCC and GSE65858, GSE41613 data. F Expression of different HRG in normal and tumor tissues (nsP > 0.05, *P < 0.05, ** P < 0.01, *** P < 0.001). G Sankey diagram showing the distribution of patients with HPV16, hypoxia clusters, gene clusters, HS, and survival status. H Correlations between HS, immune-related functions, and the abundance of each immune cell in 770 HNSCC samples. I Differences in the HS among the three hypoxia clusters. J Differences in the HS among the three gene clusters. HNSCC head and neck squamous cell carcinoma, DEGs differentially expressed genes, OS overall survival, TCGA The Cancer Genome Atlas, HRG hypoxia-related gene, HHSG high hypoxia score group, LHSG low hypoxia score group, HS hypoxia scoreBack to article page